Palliative sedation involves the use of sedative medication to relieve refractory symptoms in patients by reducing their level of consciousness. Although it is considered an acceptable clinical practice from most ethical points of view, palliative sedation is still a widely debated procedure and merits better understanding.
Methods
The relevant medical literature pertaining to palliative sedation was analyzed and reviewed from various technical, relational, and bioethical perspectives.
Results
Proportionate palliative sedation is considered to be the most clinically appropriate modality for performing palliative sedation. However, guidelines must be followed to ensure that it is performed correctly. Benzodiazepines represent the first therapeutic option and careful monitoring of dosages is essential to avoid oversedation or undersedation.
Conclusions
Proportionate palliative sedation is used to manage and relieve refractory symptoms in patients with cancer during their last days or hours of life. Evidence suggests that its use has no detrimental effect on survival. A different decision-making process is used to manage the withdrawal of hydration than the process used to determine whether proportionate palliative sedation is appropriate. Communication between patients, their relatives, and the health care staff is important during this medical intervention.
References
1.
HasselaarJ.G., VerhagenS.C., VissersK.C.. When cancer symptoms cannot be controlled: the role of palliative sedation.Curr Opin Support Palliat Care.2009; 3(1): 14–23.
2.
De GraeffA., DeanM.. Palliative sedation therapy in the last weeks of life: a literature review and recommendations for standards.J Palliat Med.2007; 10(1): 67–85.
3.
SchildmannE.K., SchildmannJ., KiesewetterI.. Medication and monitoring in palliative sedation therapy: a systematic review and quality assessment of published guidelines.J Pain Symptom Manage.2015; 49(4): 734–746.
4.
SchildmannE.K., SchildmannJ.. Palliative sedation therapy: a systematic literature review and critical appraisal of available guidance on indication and decision making.J Palliat Med.2014; 17(5): 601–611.
5.
ChernyN., RadbruchL.. The Board of the European Association for Palliative Care. European Association for Palliative Care (EAPC) recommended framework for the use of sedation in palliative care.Palliat Med.2009; 23(7): 581–593.
6.
ChernyN.I.; ESMO Guidelines Working Group. ESMO clinical practice guidelines for the management of refractory symptoms at the end of life and the use of palliative sedation.Ann Oncol.2014; 25(Suppl 3): iii143–11152.
7.
DeanM.M., CellariusV., HenryB.. Framework for continuous palliative sedation therapy in Canada.J Palliat Med.2012; 15(8): 870–879.
8.
KirkT.W., MahonM.M.; Palliative Sedation Task Force of the National Hospice and Palliative Care Organization Ethics Committee. National Hospice and Palliative Care Organization (NHPCO) position statement and commentary on the use of palliative sedation in imminently dying terminally ill patients.J Pain Symptom Manage.2010; 39(5): 914–923.
American Academy of Hospice and Palliative Medicine.Palliative sedation position statement. Published December 5, 2014. http://aahpm.org/positions/palliative-sedation. Accessed November 4, 2015.
11.
MaterstvedtL.J., ClarkD., EllershawJ.. Euthanasia and physician assisted suicide: a view from an EAPC Ethics Task Force.Palliat Med.2003; 17(2): 97–101.
12.
ten HaveH., WelieJ.V.. Palliative sedation versus euthanasia: an ethical assessment.J Pain Symptom Manage.2014; 47(1): 123–136.
13.
MaltoniM., PittureriC., ScarpiE.. Palliative sedation therapy does not hasten death: results from a prospective multicenter study.Ann Oncol.2009; 20(7): 1163–1169.
14.
MaltoniM., ScarpiE., RosatiM.. Palliative sedation in end-of-life care and survival: a systematic review.J Clin Oncol.2012; 30(12): 1378–1383.
15.
BellerE.M., van DrielM.L., McGregorL.. Palliative pharmacological sedation for terminally ill adults.Cochrane Database Syst Rev.2015; 1: CD010206.
16.
BroeckaertB., Nunez OlarteJ.. Sedation in palliative care. Facts and concepts. In: ten HaveH., ClarkD., eds. The Ethics of Palliative Care: European Perspectives.Buckingham, UK: Open University Press;2002: 166–180.
17.
BergerJ.T.. The proportionate value of proportionality in palliative sedation.J Clin Ethics.2014; 25(3): 219–221.
18.
RysS., DeschepperR., MortierF.. Continuous sedation until death with or without the intention to hasten death–a nationwide study in nursing homes in Flanders, Belgium.J Am Med Dir Assoc.2014; 15(8): 570–575.
19.
SealeC., RausK., BruinsmaS.. The language of sedation in end-of-life care: the ethical reasoning of care providers in three countries.Health (London).2015; 19(4): 339–3354.
20.
AnquinetL., RietjensJ.A., SealeC.. The practice of continuous deep sedation until death in Flanders (Belgium), the Netherlands, and the UK: a comparative study.J Pain Symptom Manage.2012; 44(1): 33–43.
21.
SwartS.J., van der HeideA., van ZuylenL.. Considerations of physicians about the depth of palliative sedation at the end of life.Can Med Ass J.2012; 184(7): E360–E366.
BroeckaertB.. Palliative sedation, physician-assisted suicide, and euthanasia: ‘same, same but different'?Am J Bioeth.2011; 11(6): 62–64.
24.
ClaessensP., MentenJ., SchotsmansP.. Palliative sedation, not slow euthanasia: a prospective, longitudinal study of sedation in Flemish palliative care units.J Pain Symptom Manage.2011; 41(1): 14–24.
25.
RausK., de LaatM., MortierE.. The ethical and clinical importance of measuring consciousness in continuously sedated patients.J Clin Ethics.2014; 25(3): 207–218.
26.
PutmanM.S., YoonJ.D., RasinskiK.A.. Intentional sedation to unconsciousness at the end of life: findings from a national physician survey.J Pain Symptom Manage.2013; 46(3): 326–334.
27.
ChernyN.I., PortenoyR.K.. Sedation in the management of refractory symptoms: guidelines for evaluation and treatment.J Palliat Care.1994; 10(2): 31–38.
28.
MaterstvedtJ.L., BosshardG.. Deep and continuous palliative sedation (terminal sedation): clinical-ethical and philosophical aspects.Lancet Oncol.2009; 10(6): 622–627.
29.
KrishnaL.K., KwekS.Y.. The changing face of personhood at the end of life: the ring theory of personhood.Palliat Support Care.2014; 3: 1–7.
30.
MenacaA., EvansN., AndrewE.. End-of-life care across southern Europe: a critical review of cultural similarities and differences between Italy, Spain and Portugal.Crit Rev Oncol Hematol.2012; 82(39): 387–401.
31.
GuX., ChengW., ChenM.. Palliative sedation for terminally ill cancer patients in a tertiary cancer center in Shanghai, China.BMC Palliat Care.2015; 14: 5.
32.
SterckxS., RausK., MortierF.. Continuous Sedation at the End-of-Life: Ethical, Clinical, and Legal Perspectives.Cambridge, UK: Cambridge University Press; 2013.
33.
CaraceniA., ZeccaE., MartiniC.. Palliative sedation at the end of life at a tertiary cancer center.Support Care Cancer.2012; 208(6): 1299–1307.
34.
MercadanteS., PorzioG., ValleA.; Home Care Italy Group. Palliative sedation in patients with advanced cancer followed at home: a systematic review.J Pain Symptom Manage.2011; 41(4): 754–760.
35.
MaltoniM., MiccinesiG., MorinoP.. Prospective observational Italian study on palliative sedation in two hospice settings: differences in case mixes and clinical care.Support Care Cancer.2012; 20(11): 2829–2836.
36.
MoritaT., AkechiT., UchitomiY.. Practices and attitudes of Japanese oncologists and palliative care physicians concerning terminal sedation: a nationwide survey.J Clin Oncol.2002; 20(3): 758–764.
37.
MercadanteS., PorzioG., ValleA.; Home Care–Italy Group. Palliative sedation in advanced cancer patients followed at home: a retrospective analysis.J Pain Symptom Manage.2012; 43(6): 1126–1130.
38.
GoncalvesF., CorderoA., AlmeidaA.. A survey of the sedation practice of Portuguese palliative care teams.Support Care Cancer.2012; 20(12): 3123–3127.
39.
JaspersB., NauckF., LindenaG.. Palliative sedation in Germany: how much do we know? A prospective survey.J Palliat Med.2012; 15(6): 672–680.
40.
KangJ.H., ShinS.H., BrueraE.. Comprehensive approaches to managing delirium in patients with advanced cancer.Cancer Treat Rev.2013; 39(1): 105–112.
41.
LawlorP.G., BushS.H.. Delirium in patients with cancer: assessment, impact, mechanisms and management.Nat Rev Clin Oncol.2015; 12(2): 77–92.
42.
TeunissenS.C., WeskerW., KruitwagenC.. Symptom prevalence in patients with incurable cancer: a systematic review.J Pain Symptom Manage.2007; 34(1): 94–104.
43.
SadlerK.. Palliative sedation to alleviate existential suffering at end-of-life: insight into a controversial practice.Can Oncol Nurs J.2012; 22(3): 195–199.
44.
van DeijckR.H., HasselaarJ.G., VerhagenS.. Determinants of the administration of continuous palliative sedation: a systematic review.J Palliat Med.2013; 16(12): 1624–1632.
45.
OostenA.W., OldenmengerW.H., van ZuylenC.. Higher doses of opioids in patients who need palliative sedation prior to death: cause or consequence?Eur J Cancer.2011; 47(15): 2341–2346.
46.
Alonso-BabarroA., Varela-CerdeiraM., Torres-VigilI.. At-home palliative sedation for end-of-life cancer patients.Palliat Med.2010; 24(5): 486–492.
47.
MoritaT., TeiY., InoueS.. Correlation of the dose of midazolam for symptom control with administration periods: the possibility of tolerance.J Pain Symptom Manage.2003; 25(4): 369–375.
48.
ShlamovitzG.Z., ElsayemA., ToddK.H.. Ketamine for palliative sedation in the emergency department.J Emerg Med.2013; 44(2): 355–357.
49.
HernandezS.L., SheynerI., StoverK.T., StewartJ.T.. Dronabinol treatment of refractory nausea and vomiting related to peritoneal carcinomatosis.Am J Hosp Palliat Care.2015; 32(1): 5–7.
50.
DietzI., SchmitzA., LampeyI., SchulzC.. Evidence for the use of Levomepromazine for symptom control in the palliative care setting: a systematic review.BMC Palliat Care.2013; 12: 2.
51.
McWilliamsK., KeeleyP.W., WaterhouseE.T.. Propofol for terminal sedation in palliative care: a systematic review.J Palliat Med.2010; 13(1): 73–76.
52.
GélinasC., FillionL., PuntilloK.A.. Validation of the critical-care pain observation tool in adult patients.Am J Crit Care.2006; 15(4): 420–427.
53.
SesslerC.N., GosnellM.S., GrapM.J.. The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients.Am J Respir Crit Care Med.2002; 166(10): 1338–1344.
54.
ArevaloJ.J., BrinkkemperT., van der HeideA.. Palliative sedation: reliability and validity of sedation scales.J Pain Symptom Manage.2012; 44(5): 704–714.
55.
Benítez-RosarioM.A., Castillo-PadrósM., Garrido-BernetB.. Appropriateness and reliability testing of the modified Richmond Agitation-Sedation Scale in Spanish patients with advanced cancer.J Pain Symptom Manage.2013; 45(6): 1112–1119.
56.
BushS.H., GrassauP.A., YarmoM.N.. The Richmond Agitation-Sedation Scale modified for palliative care inpatients (RASS-PAL): a pilot study exploring validity and feasibility in clinical practice.BMC Palliat Care.2014; 13(1): 17.
57.
DeschepperR., LaureysS., Hachimi-IdrissiS.. Palliative sedation: why we should be more concerned about the risks that patients experience an uncomfortable death.Pain.2013; 154(9): 1505–1150.
58.
BrinkkemperT., van NorelA.M., SzadekK.M.. The use of observational scales to monitor symptom control and depth of sedation in patients requiring palliative sedation: a systematic review.Palliat Med.2013; 27(1): 54–67.
59.
RysS., DeschepperR., MortierF.. The moral difference or equivalence between continuous sedation until death and physician-assisted death: word games or war games? A qualitative content analysis of opinion pieces in the indexed medical and nursing literature.J Bioeth Inq.2012; 9(2): 171–183.
60.
MoritaT., ChinoneY., IkenagaM.. Efficacy and safety of palliative sedation therapy: a multicenter, prospective, observational study conducted on specialized palliative care units in Japan.J Pain Symptom Manage.2005; 30(4): 320–328.
61.
RietjensJ.A., van DeldenJ.J., van der HeideA.. Terminal sedation and euthanasia: a comparison of clinical practices.Arch Intern Med.2006; 166(7): 749–753.
62.
HahnM.P.. Review of palliative sedation and its distinction from euthanasia and lethal injection.J Pain Palliat Care Pharmacother.2012; 26(1): 30–39.
63.
JanssensR., van DeldenJ.J., WiddershovenG.A.. Palliative sedation: not just normal medical practice. Ethical reflections on the Royal Dutch Medical Association's guideline on palliative sedation.J Med Ethics.2012; 38(11): 664–668.
64.
BrueraE., HuiD., DalalS.. Parenteral hydration in patients with advanced cancer: a multicenter, double-blind, placebo-controlled randomized trial.J Clin Oncol.2013; 31(1): 111–118.
65.
BelandP.. Ethical issues around continuous deep sedation without hydration.Nurs Times.2012; 108(38): 22–25.
66.
MiccinesiG., RietjensJ.A., DeliensL.. Continuous deep sedation: physicians’ experiences in six European countries.J Pain Symptom Manage.2006; 31(2): 122–129.
67.
HarrisonJ.D., YoungJ.M., PriceM.A.. What are the unmet supportive care needs of people with cancer? A systematic review.Support Care Cancer.2009; 17(8): 1117–1128.
BruinsmaS.M., RietjensJ.A., SeymourJ.E.. The experiences of relatives with the practice of palliative sedation: a systematic review.J Pain Symptom Manage.2012; 44(3): 431–445.
70.
Vayne-BossertP., ZulianG.B.. Palliative sedation: from the family perspective.Am J Hosp Palliat Care.2013; 30(8): 786–790.
71.
BruinsmaS., RietjensJ, van der HeideA.. Palliative sedation: a focus group study on the experiences of relatives.J Palliat Med.2013; 16(4): 1–7.
72.
RietjensJ.A., VoorheesJ.R., van der HeideA.. Approaches to suffering at the end of life: the use of sedation in the USA and Netherlands.J Med Ethics.2014; 40(4): 235–240.
73.
ArevaloJ.J., RietjensJ.A., SwartS.J.. Day-to-day care in palliative sedation: survey of nurses’ experiences with decision-making and performance.Int J Nurs Stud.2013; 50(5): 613–621.
74.
GielenJ., Van den BrandenS.. Flemish palliative-care nurses’ attitudes to palliative sedation: a quantitative study.Nurs Ethics.2012; 19(5): 692–704.
75.
PatelB., Gorawara-BhatR., LevineS.. Nurses’ attitudes and experiences surrounding palliative sedation: components for developing policy for nursing professionals.J Palliat Med.2012; 15(4): 432–437.
76.
Benitez-RosarioM.A., Castillo-PadrósM., Garrido-BernetB.. Quality of care in palliative sedation: audit and compliance monitoring of a clinical protocol.J Pain Symptom Manage.2012; 44(4): 532–541.
77.
KoperI., van der HeideA., JanssensR.. Consultation with specialist palliative care services in palliative sedation: considerations of Dutch physicians.Support Care Cancer.2014; 22(1): 225–231.
